XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Benefit
Income tax benefit consists of the following:
Years Ended December 31,Six-month Transition Period Ended December 31,Year Ended June 30,
(in millions)2022202120202020
Current:
Federal$(0.5)$(1.9)$(75.8)$26.6 
State1.9 3.6 (0.6)4.9 
Foreign0.5 0.1 0.2 0.5 
Total current1.9 1.8 (76.2)32.0 
Deferred:
Federal(25.8)(33.7)39.1 (51.5)
State(4.8)5.1 (3.4)(4.1)
Foreign(2.9)0.1 (0.5)(3.6)
Change in valuation allowance3.0 (3.2)— 3.5 
Total deferred(30.5)(31.7)35.2 (55.7)
Total income tax benefit$(28.6)$(29.9)$(41.0)$(23.7)
Schedule of Loss Before Income Taxes
Loss before income taxes consists of the following:
Years Ended December 31,Six-month Transition Period Ended December 31,Year Ended June 30,
(in millions)2022202120202020
United States$(141.3)$(53.8)$(101.8)$(240.9)
Foreign0.7 (3.3)7.7 17.6 
Total$(140.6)$(57.1)$(94.1)$(223.3)
Schedule of Differences Between Statutory Federal Income Tax Rate and Income Taxes Reported
The differences between income taxes at the statutory federal income tax rate and income taxes reported in the Consolidated Statements of Operations were as follows:
Years Ended December 31,Six-month Transition Period Ended December 31,Year Ended June 30,
(in millions)2022202120202020
Federal income tax expense at the statutory rate$(29.5)21.0 %$(12.0)21.0 %$(19.8)21.0 %$(46.9)21.0 %
State income taxes, net of federal benefit(3.3)2.3 %(1.8)3.2 %(1.2)1.3 %4.0 (1.8)%
Research and development credits(3.5)2.5 %2.5 (4.4)%(1.3)1.4 %(2.8)1.3 %
Uncertain tax positions0.6 (0.4)%(3.0)5.3 %0.6 (0.7)%1.5 (0.7)%
Incentive stock option and employee stock purchase plan expense2.5 (1.8)%0.7 (1.2)%2.5 (2.7)%(0.2)0.1 %
Foreign rate differential— — %0.5 (0.9)%(2.1)2.2 %0.7 (0.3)%
Change in valuation allowance2.6 (1.8)%(3.2)5.6 %(0.3)0.3 %3.5 (1.7)%
CARES Act— — %2.7 (4.7)%(20.7)22.0 %— — %
Non-deductible meals and entertainment— — %0.1 (0.2)%0.5 (0.5)%1.8 (0.8)%
Non-deductible officer compensation3.5 (2.5)%3.3 (5.8)%0.1 (0.1)%1.6 (0.7)%
Asset impairment— — %— — %— — %12.6 (5.6)%
Non-deductible legal settlement— — %2.5 (4.5)%— — %— — %
Acquisitions, dispositions, and contingent consideration(0.1)0.1 %(23.0)40.3 %0.7 (0.7)%(0.3)0.1 %
Other, net(1.4)0.9 %0.8 (1.4)%— — %0.8 (0.3)%
Total income tax benefit$(28.6)20.3 %$(29.9)52.3 %$(41.0)43.5 %$(23.7)10.6 %
Schedule of Components of Deferred Tax Assets and Liabilities
The significant components of the Company’s deferred tax assets and liabilities were comprised of the following:
December 31,
(in millions)20222021
Deferred tax assets:
Net operating loss carryforwards$66.6 $67.2 
Deferred revenue0.2 1.2 
Stock compensation expense3.6 4.5 
Research and development credits19.9 17.3 
Lease liability35.2 22.4 
Section 174 capitalized costs21.2 — 
Accrued expenses and liabilities10.8 14.2 
Other, net3.4 4.5 
Total gross deferred tax assets160.9 131.3 
Less valuation allowance(42.4)(38.5)
Total deferred tax assets118.5 92.8 
Deferred tax liabilities:
Intangible assets93.8 104.9 
Lease right-of-use assets25.4 20.2 
Property, plant and equipment2.8 3.5 
Total deferred tax liabilities122.0 128.6 
Net deferred tax liability$(3.5)$(35.8)
Schedule of Net Operating Loss and Research Credit Carryforwards (Tax Effected)
At December 31, 2022, the Company had the following net operating loss and research credit carryforwards (tax effected), with their respective expiration periods. Certain carryforwards are subject to the limitations of Section 382 and 383 of the Internal Revenue Code as indicated (in millions):
CarryforwardsAmountSubject to
sections 382, 383
Expires
beginning in year
Through
Federal net operating loss$26.6 Yes2033Indefinite
Federal capital loss13.5 No 20262026
Utah net operating loss2.8 No2023Indefinite
California net operating loss4.4 Yes20292041
Other state net operating loss7.7 YesVariousVarious
Foreign net operating losses (various jurisdictions)11.6 NoVariousVarious
Federal research credit8.7 Yes20272042
Utah research credit6.9 No20232036
California research credit4.4 NoIndefiniteIndefinite
Schedule of Unrecognized Tax Benefits The Company’s gross unrecognized tax benefits as of the years ended December 31, 2022 and 2021, the transition period ended December 31, 2020 and the fiscal year ended June 30, 2020, and the changes in those balances are as follows: 
Years Ended December 31,Six-month Transition Period Ended December 31,Year Ended June 30,
(in millions)2022202120202020
Unrecognized tax benefits at the beginning of period$32.1 $37.6 $23.5 $21.7 
Gross increases - current year tax positions0.9 1.4 13.9 1.6 
Gross increases - prior year tax positions1.6 1.1 1.0 0.7 
Gross decreases - prior year tax positions(2.0)(2.8)(0.1)— 
Gross decreases - settlements(0.7)(5.1)— — 
Gross decreases - statute lapse— (0.1)(0.7)(0.5)
Unrecognized tax benefits at end of year$31.9 $32.1 $37.6 $23.5 
Interest and penalties in year-end balance$4.1 $3.3 $2.2 $1.4